Development of a screening approach to interpret human biomonitoring data on volatile organic compounds: Reverse dosimetry on biomonitoring data for trichloroethylene

Risk Analysis

Volumn 27, Issue 5, 2007, Pages 1223-1236

  Liao, Kai H ^a,b   Tan, Yu Mei ^a   Clewell III, Harvey J ^a  

^a CIIT CENTERS FOR HEALTH RESEARCH   (United States)

^b WYETH RESEARCH   (United States)

Author keywords

Monte Carlo; PBPK modeling; QSPR; Reverse dosimetry; Trichloroethylene

Indexed keywords

DATA ACQUISITION; DOSIMETRY; MATHEMATICAL MODELS; MONTE CARLO METHODS; VOLATILE ORGANIC COMPOUNDS;

PBPK MODELING; QUANTITATIVE STRUCTURE PROPERTY RELATIONSHIPS (QSPR); REVERSE DOSIMETRY;

TRICHLOROETHYLENE;

TRICHLOROETHYLENE; VOLATILE ORGANIC COMPOUND;

BIOMONITORING; BLOOD; COMPARATIVE STUDY; DRINKING WATER; GUIDELINE; HEALTH RISK; MODELING; MONTE CARLO ANALYSIS; PHYSIOLOGY; REACTION KINETICS; TRICHLOROETHYLENE; VOLATILE ORGANIC COMPOUND;

ARTICLE; BIOLOGICAL MONITORING; CHEMICAL ANALYSIS; CONTROLLED STUDY; DOSIMETRY; ENVIRONMENTAL EXPOSURE; FLUID INTAKE; HEALTH HAZARD; HUMAN; MATHEMATICAL ANALYSIS; MONTE CARLO METHOD; PROTON NUCLEAR MAGNETIC RESONANCE; SCREENING;

DATA INTERPRETATION, STATISTICAL; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; HUMANS; MODELS, STATISTICAL; MONTE CARLO METHOD; ORGANIC CHEMICALS; RISK ASSESSMENT; TRICHLOROETHYLENE; VOLATILIZATION; WATER POLLUTANTS, CHEMICAL;

EID: 36849035487     PISSN: 02724332     EISSN: 15396924     Source Type: Journal    
DOI: 10.1111/j.1539-6924.2007.00964.x     Document Type: Article

References (43)

1. ACGIH 2003). 2003 TLVs and BEIs Based on the Documentation of the Threshold Limit Values for Chemical Substances and Physical Agents & Biological Exposure Indices. Cincinnati, OH : American Conference of Governmental Industrial Hygienists.
2. CDC 2005). Third National Report on Human Exposure to Environmental Chemicals. NCEH 05-0570. Atlanta, GA : National Center for Environmental Health, Centers for Disease Control and Prevention.
3. U.S. EPA 2006). SAB Review of EPA's Draft Risk Assessment of Potential Human Health Effects Associated with PFOA and Its Salts. EPA-SAB-06-006. Washington, DC.
4. Clewell, H. J., Gentry, P. R., Covington, T. R., & Gearhart, J. M. (2000). Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment. Environmental Health Perspectives, 108 (Suppl. 2 283 305.
5. Clewell, H. J., Gentry, P. R., Gearhart, J. M., Allen, B. C., & Andersen, M. E. (2001). Comparison of cancer risk estimates for vinyl chloride using animal and human data with a PBPK model. Science of the Total Environment, 274, 37 66.
6. Ramsey, J. C., & Andersen, M. E. (1984). A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans. Toxicology and Applied Pharmacology, 73, 159 175.
7. Sarangapani, R., Teeguarden, J. G., Cruzan, G., Clewell, H. J., & Andersen, M. E. (2002). Physiologically based pharmacokinetic modeling of styrene and styrene oxide respiratory-tract dosimetry in rodents and humans. Inhalation Toxicology, 14, 789 834.
8. Andersen, M. E., Clewell, H. J., Gargas, M. L., Macnaughton, M. G., Reitz, R. H., Nolan, R. J., & McKenna, M. J. (1991). Physiologically based pharmacokinetic modeling with dichloromethane, its metabolite, carbon-monoxide, and blood carboxyhemoglobin in rats and humans. Toxicology and Applied Pharmacology, 108, 14 27.
9. Clewell, H. J., Gentry, P. R., Kester, J. E., & Andersen, M. E. (2005). Evaluation of physiologically based pharmacokinetic models in risk assessment: An example with perchloroethylene. Critical Reviews in Toxicology, 35, 413 433.
10. Clewell, H. J., Gentry, P. R., Gearhart, J. M., Covington, T. R., Banton, M. I., & Andersen, M. E. (2001). Development of a physiologically based pharmacokinetic model of isopropanol and its metabolite acetone. Toxicological Sciences, 63, 160 172.
11. CDC 1996). The Third National Health and Nutrition Examination Survey (NHANES III, 1988-94). Atlanta, GA : National Center for Health Statistics.
12. Brown, R. P., Delp, M. D., Lindstedt, S. L., Rhomberg, L. R., & Beliles, R. P. (1997). Physiological parameter values for physiologically based pharmacokinetic models. Toxicology and Industrial Health, 13, 407 484.
13. Clewell, H. J., Gentry, P. R., Covington, T. R., Sarangapani, R., & Teeguarden, J. G. (2004). Evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry. Toxicological Sciences, 79, 381 393.
14. Poulin, P., & Krishnan, K. (1999). Molecular structure-based prediction of the toxicokinetics of inhaled vapors in humans. International Journal of Toxicology, 18, 7 18.
15. Beliveau, M., Lipscomb, J., Tardif, R., & Krishnan, K. (2005). Quantitative structure-property relationships for interspecies extrapolation of the inhalation pharmacokinetics of organic chemicals. Chemical Research in Toxicology, 18, 475 485.
16. max) of halogenated methanes, ethanes, and ethylenes. Toxicology Letters, 43, 235 256.
17. Gargas, M. L., Burgess, R. J., Voisard, D. E., Cason, G. H., & Andersen, M. E. (1989). Partition coefficients of low-molecular-weight volatile chemicals in various liquids and tissues. Toxicology and Applied Pharmacology, 98, 87 99.
18. Poulin, P., & Krishnan, K. (1996). Molecular structure-based prediction of the partition coefficients of organic chemicals for physiological pharmacokinetic models. Toxicology Methods, 6, 117 137.
19. Hine, J., & Mookerjee, P. K. (1975). Intrinsic hydrophilic character of organic compounds - Correlations in terms of structural contributions. Journal of Organic Chemistry, 40, 292 298.
20. Leeper, S. C., Almatari, A. L., Ingram, J. D., & Ferslew, K. E. (2000). Topical absorption of isopropyl alcohol induced cardiac and neurologic deficits in an adult female with intact skin. Veterinary and Human Toxicology, 42, 15 17.
21. Lacouture, P. G., Heldreth, D. D., Shannon, M., & Lovejoy, F. H. (1989). The generation of acetonemia acetonuria following ingestion of a subtoxic dose of isopropyl alcohol. American Journal of Emergency Medicine, 7, 38 40.
22. Little, J. C. (1992). Applying the two-resistance theory to contaminant volatilization in showers. Environmental Science & Technology, 26, 1341 1349.
23. Weisel, C. P., Little, J. C., Chiu, N., Pandis, S. N., Davidson, C., & Wilkes, C. R. 1998). Developing exposure estimates. In S. S. Olin (Ed Exposure to Contaminants in Drinking Water. Washington, DC : International Life Sciences Institute.
24. Wilkes, C. R., Small, M. J., Andelman, J. B., Giardino, N. J., & Marshall, J. (1992). Inhalation exposure model for volatile chemicals from indoor uses of water. Atmos Environ, 26A, 2227 2236.
25. Tan, Y. M., Liao, K. H., Conolly, R. B., Blount, B. C., Mason, A. M., & Clewell, H. J. (2006). Use of a physiologically based pharmacokinetic model to identify exposures consistent with human biomonitoring data for chloroform. Journal of Toxicology and Environmental Health, Part A, 69, 1727 1756.
26. U.S. EPA (1987). The Total Exposure Assessment Methodology (TEAM) Study: Elizabeth and Bayonne, New Jersey, Devils Lake, North Dakota and Greensboro, North Carolina: Volume II. EPA/600/6-87/002b. Washington, DC : Office of Research and Development, U.S. Environmental Protection Agency.
27. U.S. EPA (1987). The Total Exposure Assessment Methodology (TEAM) Study. Selected Communities in Northern and Southern California: Volume III. EPA/600/6-87/002c. Washington, DC : Office of Research and Development, U.S. Environmental Protection Agency.
28. U.S. EPA (2000). Estimated per Capita Water Ingestion in the United States. Based on Data Collected by the United States Department of Agriculture's 1994-96 Continuing Survey of Food Intakes by Individuals. EPA-822-R-00-008. Washington, DC : Office of Water.
29. U.S. EPA (1996). Descriptive Statistics Tables from a Detailed Analysis of the National Human Activity Pattern Survey (NHAPS) data. EPA/600/R-96/148. Washington, DC : Office of Research and Development.
30. Mayer, P. W., DeOreo, W. B., Optiz, E. M., Kiefer, J. C., Davis, W. Y., Dziegielewski, B., & Nelson, J. O. (1999). Residential End Uses of Water. Denver : AWWA Research Foundation.
31. Levesque, B., Ayotte, P., Tardif, R., Ferron, L., Gingras, S., Schlouch, E., Gingras, G., Levallois, P., & Dewailly, E. (2002). Cancer risk associated with household exposure to chloroform. J Toxicol Environ Health A, 65, 489 502.
32. U.S. EPA (1987). The Total Exposure Assessment Methodology (TEAM) Study: Summary and Analysis: Volume I. EPA/600/6-87/002a. Washington, DC : Office of Research and Development, U.S. Environmental Protection Agency.
33. Ashley, D. L., Bonin, M. A., Cardinali, F. L., McCraw, J. M., & Wooten, J. V. (1994). Blood-concentrations of volatile organic-compounds in a nonoccupationally exposed US population and in groups with suspected exposure. Clinical Chemistry, 40, 1401 1404.
34. Payne, M. P., & Kenny, L. C. (2002). Comparison of models for the estimation of biological partition coefficients. J Toxicol Environ Health A, 65, 897 931.
35. Meulenberg, C. J. W., & Vijverberg, H. P. M. (2000). Empirical relations predicting human and rat tissue: air partition coefficients of volatile organic compounds. Toxicology and Applied Pharmacology, 165, 206 216.
36. Paterson, S., & Mackay, D. (1989). Correlation of tissue, blood, and air partition coefficients of volatile organic chemicals. British Journal of Industrial Medicine, 46, 321 328.
37. Gentry, P. R., Hack, C. E., Haber, L., Maier, A., & Clewell, H. J., 3rd. (2002). An approach for the quantitative consideration of genetic polymorphism data in chemical risk assessment: Examples with warfarin and parathion. Toxicological Science, 70, 120 39.
38. Wallace, L. A. (1986). Personal exposures, indoor and outdoor air concentrations, and exhaled breath concentrations of selected volatile organic compounds measured for 600 residents of New Jersey, North Dakota, North Carolina and California. Toxicological and Environmental Chemistry, 12, 215 236.
39. Wallace, L. A., Pellizzari, E. D., Hartwell, T. D., Sparacino, C. M., Sheldon, L. S., & Zelon, H. (1985). Personal exposures, indoor outdoor relationships, and breath levels of toxic air pollutants measured for 355 persons in New Jersey. Atmospheric Environment, 19, 1651 1661.
40. ATSDR (1997). Toxicological Profile for Trichloroethylene. Atlanta, GA : U.S. Department of Health and Human Services, Agency for Toxic Substances and Disease Registry.
41. Clewell, H. J., Gearhart, J. M., Gentry, P. R., Covington, T. R., VanLandingham, C. B., Crump, K. S., & Shipp, A. M. (1999). Evaluation of the uncertainty in an oral reference dose for methylmercury due to interindividual variability in pharmacokinetics. Risk Analysis, 19, 547 558.
42. Sohn, M. D., McKone, T. E., & Blancato, J. N. (2004). Reconstructing population exposures from dose biomarkers: inhalation of trichloroethylene (TCE) as a case study. Journal of Exposure Analysis and Environmental Epidemiology, 14, 204 213.
43. Georgopoulos, P. G., Roy, A., & Gallo, M. A. (1994). Reconstruction of short-term multiroute exposure to volatile organic-compounds using physiologically-based pharmacokinetic models. Journal of Exposure Analysis and Environmental Epidemiology, 4, 309 328.